Siemens Atellica IM Hepatitis B surface Antigen II (HBsII)
- Registration number
- DE0510275
- Model name
- Atellica IM Hepatitis B surface Antigen II (HBsII); Atellica IM HBsII QC; Atellica IM PW3
- Model identifier
- 10995604; 10995605; 10995666
- Registration date
- January 22, 2025
- Source update date
- March 07, 2025
- Risk class
- Class D
- Product owner
- Siemens Healthcare Diagnostics Inc
- Registrant / registration holder
- SIEMENS HEALTHCARE PTE. LTD.
The Atellica® IM Hepatitis B surface Antigen II (HBsII) assay is for in vitro diagnostic use in the qualitative detection of hepatitis B surface antigen (HBsAg) in human serum and plasma (EDTA, lithium heparin and sodium heparin) using the Atellica® Analyzer. The assay may be used in conjunction with other serological and clinical information to diagnose individuals (neonates, infants, children, adolescents, and adults) with acute or chronic hepatitis B infection. The assay may be used to screen for hepatitis B infection in pregnant women to identify neonates who are at risk of acquiring hepatitis B during the perinatal period. The assay may be used for screening donors whose blood or blood products are intended for transfusion or for further manufacture, or to screen donors whose cells, tissues, and organs are intended for transplant. Specimens may be obtained while the donor's heart is still beating, or from cadaveric (non‑heart‑beating) donors.
- Product owner address
- 511 Benedict Avenue, Tarrytown, NY 10591, United States
- Registrant address
- 60 MACPHERSON ROAD, THE SIEMENS CENTRE, Singapore 348615
This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.